Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer - Poll - MDSpire

Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer

A new study from Dana-Farber Cancer Institute finds that patients with NUT carcinoma (NC), an aggressive squamous cell lung or head and neck cancer, often face delays in diagnosis—delays that can prevent them from receiving the right treatment or joining clinical trials.

  • By

  • December 8, 2025

  • 3 min

Share

Original Source(s)

Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer

  • by

  • December 8, 2025

Related Content

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series